Mike Westby

Mike Westby is the Chief Executive Officer of RQ Biotechnology Ltd., a company focused on providing instant immunity to vulnerable populations through engineered antibodies. Prior to their current role, Mike served as the Chief Scientific Officer and CEO at Centauri Therapeutics Limited, where Mike led the development of novel molecules targeting life-threatening diseases. Mike also co-founded Avvinity Therapeutics and held leadership positions at Loxbridge Research, Pfizer Global Research and Development, Roche R&D, and F. Hoffmann-La Roche Ltd. Mike holds a Post Doctoral Studies degree from St George's, University of London, a PhD in Molecular Biology from the University of Warwick, and a Bsc Hons in Molecular Biology Biochemistry from Durham University.